109 filings
Page 4 of 6
8-K
wowen7uld543j59
20 Feb 20
Termination of a Material Definitive Agreement
6:01am
8-K
easdxlx4
10 Jan 20
Matinas BioPharma Announces Proposed Public Offering of Common Stock
4:50pm
8-K
1pdzys9i ui
1 Nov 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
2nsj2kbc5tutrwpwma8
13 Aug 19
Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7:00am
8-K
ih74dxft2h4rfb jxjt
14 May 19
Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results
7:05am
8-K
ukq7onn
2 Apr 19
Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update
7:20am
8-K
akabex p1
15 Mar 19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
5:15pm
8-K
95kynxp787
25 Feb 19
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
8:15am
8-K
hmva0ub 4muabd
3 Jan 19
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
8:05am
8-K
c8rb28r
2 Nov 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
2bua9pq 8sxwxq4v
15 Oct 18
Departure of Directors or Certain Officers
8:00am
8-K
zu68qihphdl z4zs
6 Sep 18
Matinas BioPharma Announces Appointment of Industry Leader Patrick G. LePore to Board of Directors
12:00am
8-K
61rxzb4t5fui
19 Jun 18
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
5:19pm
8-K
v761qsaxr8ro6lwa
18 Jun 18
Departure of Directors or Certain Officers
5:23pm
8-K
mqe9 3995
25 May 18
Other Events
11:17am
8-K
2dbv30l
27 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
yb2fbzuhn0k3j6q
8 Jan 18
Other Events
12:00am
8-K
stz0343rw oed
14 Dec 17
Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors
12:00am
8-K
97zy026t3i jprrwv
26 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
tm0m6dy
10 Aug 17
Regulation FD Disclosure
12:00am